Dr. Lucinda Bateman, MD

Dr. Bateman practices at Evanston Regional Hospital in Evanston, Wyoming, part of Quorum Health.

Dr. Bateman's NPI, 1346210267, was assigned on January 24, 2006. Dr. Bateman graduated from The Johns Hopkins University School of Medicine in 1987. Dr. Bateman holds Utah license 178153 1205.

Dr. Bateman's primary practice is Evanston Regional Hospital, at 190 Arrowhead Dr, Evanston, WY 82930 in Uinta County. The practice phone is (307) 789-3636.

Dr. Bateman's primary practice is Evanston Regional Hospital in Evanston, Wyoming, part of Quorum Health. The medical group on file is Bateman Horne Center. Dmand AI also links Dr. Bateman to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bateman practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bateman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Bateman is licensed in Utah.

Dmand AI lists fibromyalgia and chronic pain, insomnia, low blood pressure and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Bateman treats.

CMS data shows 124 Medicare services from Dr. Bateman across 2 procedure codes in 2024, all of them office visits, for 48 Medicare patients. Medicare paid $12,369 for them. Every service was in an office.

CMS counts 48 Medicare patients who saw Dr. Bateman in 2024. The largest group is 65 to 74, with 20 patients. 60% of them have high cholesterol, and 54% have anxiety. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bateman's median patient age at 52, with 75% women.

In 2024, Dr. Bateman wrote 1,613 Medicare Part D claims for 68 patients. 93% of them were for generic drugs. CMS names the drug for 1,224 of them, across 47 drugs with 11 or more claims each, at $37,202 in total drug cost. In 2023, CMS named 1,191 claims across 48 drugs.

Dmand AI links 65 papers to Dr. Bateman, published from 2010 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Fatigue Syndrome, Chronic, COVID-19 and Fibromyalgia. Dr. Bateman has published most often in Front Med (Lausanne). Dr. Bateman's most frequent co-authors are Daniel L. Peterson, MD, Nancy G. Klimas, MD and Jose G. Montoya, MD.

Dmand AI links Dr. Bateman to 15 clinical trials, 4 of them phase 3 studies. Conditions studied include Fibromyalgia, Muscular Diseases and Fatigue Syndrome, Chronic. Pfizer's Upjohn has merged with Mylan to form Viatris Inc. sponsors the most, 4. Open Payments lists research payments to Dr. Bateman that name 2 trials.

CMS Open Payments shows 116 general payments to Dr. Bateman from 26 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 69% of the total. Pfizer Inc. paid the most, $4,008. It also lists 31 research payments totaling $28,899 from 2016 to 2019, naming 2 clinical trials.

Dmand AI lists 1 award for Dr. Bateman, most recently Governor Rudy Perpich Award in 2016.

Dr. Bateman graduated from The Johns Hopkins University School of Medicine in 1987. Dr. Bateman is a member of International Association of CFS/ME.

Dr. Bateman is in network with 4 carriers, including HCSC, Humana and Regence Health Plans. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.